Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Escalating Doses of GSK1325756 Solution for Infusion, and Absolute Bioavailability Relative of an Oral Dose, in Healthy Adult Subjects

Solution containing 2 mg/mL GSK1325756 in sterile water for injection, to be administered intravenously.

Solution containing sterile water for injection matching GSK1325756 solution, to be administered intravenously.

A white film coated tablet containing 50 mg GSK1325756 to be administered orally.

A white film coated tablet matching GSK1325756 tablet, to be administered orally.